tirzepatide pregnancy human data safety guidelines before and Planning Can the new diabetes and – Does Tirzepatide Cause Birth Defects?

Tirzepatide combines two classes of medications: GLP-1 and GIP whereas Semaglutide is just the GLP-1

According to various studies 56.9% decrease in insulin resistance, 1.9 percentage point decrease in HbA1c and elimination of drug dependence in many individuals was observed in as little as 90 days of starting the strategy (143)

Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin

POR, cytochrome P450 oxidoreductase

Further innovation is seen in triple agonists such as retatrutide, which targets GIP, GLP-1, and glucagon receptors to amplify metabolic effects

doi: 10.1016/j.cimid.2019.02.010